PRP FAQs
Platelet-rich plasma (PRP) is a cutting-edge therapy that utilizes the body’s own healing power to treat a variety of musculoskeletal conditions including sports-related injuries of the muscles, tendons and ligaments, and osteoarthritis. Platelet-rich plasma therapies have been used for various indications for over thirty years for musculoskeletal conditions. In some cases, Platelet-rich plasma therapy is an alternative to surgery.
Platelets are best known for their blood clotting ability, but they are a natural reservoir of hundreds of biologically active proteins called growth factors that play a key role in wound healing and tissue repair. When there is an injury or inflammation, platelets flood the area to stop bleeding and heal damaged tissues.
Platelet – rich Plasma therapy is a medical treatment that uses a concentration of a patient’s own platelets to accelerate healing and decrease inflammation in injured or diseased tissues. Platelets are a component of blood that plays a crucial role in healing processes. Platelet-rich plasma therapy involves extracting a small amount of the patient’s blood, processing it to increase the concentration of platelets, and then injecting the Platelet-rich plasma into the area that requires healing and/or symptomatic relief.
A small amount of the patient’s blood is drawn from the arm and spun in a centrifuge to separate the platelets from other blood cells in order to increase platelet concentrations. The resulting Platelet-rich plasma contains 2 to 10 times the concentration of platelets found in normal blood. For example, autologous conditioned plasma (ACP) has a platelet concentration ~2.5-3.0x whole blood. On the other hand ACP Max contains a 6-8x concentration of platelets. Another popular treatment called N-Stride contains > 5x platelets relative to whole blood but also has high concentrations of a powerful anti-inflammatory factor called interleukin-1 receptor antagonist protein (IL-1 RAP). Upon processing a patients’ blood sample, the concentrated platelets and growth factors are injected at the site of patient’s injury or damage such as into an arthritic joint, or into the zone of muscle damage following a sporting injury.
Platelet-rich plasma has found a wide range of applications in orthopedics, making it a valuable treatment option for various musculoskeletal conditions. Here are some of the key orthopedic applications of Platelet-rich plasma:
- Osteoarthritis: Platelet-rich plasma is increasingly used to manage osteoarthritis, a degenerative joint disease that causes pain and limited mobility. Injections of Platelet-rich plasma into arthritic joints can reduce pain, improve function, decrease inflammation and swelling, and potentially slow down the progression of the disease.
- Tendon Injuries: Tendon injuries, such as tennis elbow, Achilles tendonitis, and rotator cuff tears, can be treated with Platelet-rich plasma Platelet-rich plasma helps stimulate tendon healing, reduce pain, and improve tendon strength.
- Muscle Injuries: Platelet-rich plasma has shown promise in treating muscle injuries, such as strains and tears. It can accelerate muscle repair and reduce the time required for athletes to return to sports. An example of this is for hamstring and calf injuries in sprinting athletes.
Platelet-rich plasma works by utilizing the growth factors and proteins in the platelets to decrease inflammation and in some instances stimulate tissue repair and regeneration. When injected into the damaged area, the concentrated platelets release growth factors over a period of hours to days that stimulate the body’s natural healing processes. This can help to reduce inflammation, promote tissue regeneration, and accelerate healing. Occasionaly multiple injections result in an additive dosing effect on target tissues.
PRP therapy is very safe with a low incidence of adverse events. The most common side effects include temporary pain and discomfort at the site of the injection which subsides after several days. Because PRP is derived from your own blood and is minimally manipulated, the risk of adverse reactions remains low.
- Pain relief
- Decreased inflammation
- Tissue healing in some micro-environments (e.g. muscle tears)
- Restoration of function
Platelet-rich plasma therapy is generally considered safe because it uses the patient’s own blood, reducing the risk of allergic reactions or infections. However, there are some potential side effects and risks, including:
- Pain at the injection site
- Swelling or bruising
- Infection (though rare)
- Temporary increase in inflammation or pain following the injection
The number of platelet-rich plasma injections required varies based on the condition being treated, the severity of the injury, the type of PRP product and the patient’s response to the therapy. Some patients may experience improvement after a single injections, while others may require multiple injections spaced a few weeks apart. In general, 2-3 ACP injections are needed whereas a single injection in indicated when ACP Max and/or N-Stride is used.
The time it takes to see results from Platelet-rich plasma therapy can vary. Some patients may notice improvement in their symptoms within a few weeks, while others may take several months to experience the full benefits. The response to Platelet-rich plasma therapy is influenced by factors such as the severity of the condition, the area being treated, and the individual’s overall health.
Platelet-rich plasma therapy is a versatile treatment option with the potential to accelerate healing and provide relief from various conditions. Contact Hyper Regen Sports Medicine in Toronto, Canada to schedule a consultation to learn more. We offer cutting edge therapies to aid in your healing and recovery. Our goal is to treat your symptoms and restore your function so that you can enjoy a good quality of life including participating in the sports you love.
References
- Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci. 2020 Oct 21;21(20):7794. doi: 10.3390/ijms21207794. PMID: 33096812; PMCID: PMC7589810.
- Shyla Gupta, Anna Paliczak & Diego Delgado (2021) Evidence-based indications of platelet-rich plasma therapy, Expert Review of Hematology, 14:1, 97-108, DOI: 10.1080/17474086.2021.1860002
At a Glance
Dr. Jas Chahal
- Head of Orthopaedic Surgery, Women’s College Hospital
- Team Physician Toronto FC and University of Toronto Varsity Blues
- Associate Professor, University of Toronto Orthopaedic Sports Medicine Program
- Has more than 100 peer-reviewed publications
- Learn more